Total tau levels are significantly decreased in the healthy older brains compared to the younger brains. حسب Shreyasi Chatterjee (3531506)

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. حسب Xiang-Fan Chen (13932983)

Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines. حسب Nazima Nasrullah (6874496)

Chemicals that decrease the expression levels of significant TWAS genes negatively associated with UF. حسب Gayeon Kim (671557)

The distribution of <i>Giardia duodenalis</i> assemblages in domestic and wild populations of nonhuman mammalian species with a larger number of isolates. حسب Kareem Hatam-Nahavandi (7384790)

الموضوعات:

Table_1_Potential Impact of Umbilical-Cord-Blood Procalcitonin-Based Algorithm on Antibiotics Exposure in Neonates With Suspected Early-Onset Sepsis.docx حسب Noémie Huetz (8271138)

"…</p><p>Conclusion: These results suggest that the umbilical-cord-blood PCT-based algorithm could significantly help the clinicians in their antibiotic prescription decision to decrease neonatal antibiotics exposure as compared with current practice. …"

Top 20 genes with significantly decreased abundance in Aco^R cells. حسب Pieter C. Steketee (10024552)

الموضوعات:

Networks favouring more connected individuals results in a significant decrease to the likelihood of network recovery. حسب Adam Lee Miles (14123916)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

<i>Lp</i> knockdown significantly impairs oogenesis and affects Vg localization. حسب Iryna Stryapunina (17867390)

Ordination of butterfly community composition change through time. حسب Nicole B. Kucherov (11558817)

الموضوعات:

CBP per cumulative year for daratumumab and pembrolizumab per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

S4 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

S1 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

S5 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

S3 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

S6 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

CBP per cumulative indication for daratumumab and pembrolizumab per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. حسب R. J. S. D. Heine (17889199)

الموضوعات: